Nautilus Biotechnology, Inc. - Common Stock (NQ:NAUT)

3.140 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 29, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Nautilus Biotechnology, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

Nautilus Biotechnology to Participate in Upcoming August Investor Conferences

August 04, 2023

From Nautilus Biotechnology Inc.

Via GlobeNewswire

Nautilus Biotechnology Reports Second Quarter 2023 Financial Results

August 02, 2023

From Nautilus Biotechnology Inc.

Via GlobeNewswire

Nautilus Biotechnology to Announce Second Quarter Financial Results on August 2, 2023

July 11, 2023

From Nautilus Biotechnology Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

July 06, 2023

Via Benzinga

Recap: Nautilus Biotechnology Q3 Earnings ↗

November 01, 2022

Nautilus Biotechnology (NASDAQ:NAUT) reported its Q3 earnings results on Tuesday, November 1, 2022 at 06:05 AM. Here's what investors need to know about the announcement.

Via Benzinga

Recap: Nautilus Biotechnology Q2 Earnings ↗

August 02, 2022

Nautilus Biotechnology (NASDAQ:NAUT) reported its Q2 earnings results on Tuesday, August 2, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Why Avid Bioservices Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

June 22, 2023

Gainers Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE) shares climbed 422% to $0.5572 after the company announced acquisition of Spyre Therapeutics and concurrent oversubscribed $210 million private...

Via Benzinga

Top 5 Health Care Stocks That May Crash This Month ↗

June 22, 2023

The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.

Via Benzinga

Nautilus Biotechnology to Participate in Upcoming June Investor Conferences

May 24, 2023

From Nautilus Biotechnology Inc.

Via GlobeNewswire

Nautilus Biotechnology Reports First Quarter 2023 Financial Results

May 02, 2023

From Nautilus Biotechnology Inc.

Via GlobeNewswire

Nautilus Biotechnology to Announce First Quarter Financial Results on May 2, 2023

April 18, 2023

From Nautilus Biotechnology Inc.

Via GlobeNewswire

Nautilus Biotechnology to Participate in B. Riley Securities’ Disruptive Biotech Enabling Technologies – Proteomics, Virtual Conference

March 23, 2023

From Nautilus Biotechnology Inc.

Via GlobeNewswire

Nautilus Biotechnology Announces “First Access Challenge” Winners

March 07, 2023

Researchers from Buck Institute for Research on Aging, Brigham Young University and University of Southern California awarded early access to Nautilus’ single-molecule protein analysis platform

From Nautilus Biotechnology Inc.

Via GlobeNewswire

Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2022 Financial Results

February 23, 2023

From Nautilus Biotechnology Inc.

Via GlobeNewswire

Nautilus Biotechnology to Participate in the 43rd Annual Cowen Health Care Conference

February 21, 2023

From Nautilus Biotechnology Inc.

Via GlobeNewswire

Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023

January 26, 2023

From Nautilus Biotechnology Inc.

Via GlobeNewswire

Nautilus Biotechnology Expands to San Diego

January 26, 2023

Proteomics company opens new office in Southern California to facilitate ongoing research and team growth aimed at unlocking the potential of the proteome

From Nautilus Biotechnology Inc.

Via GlobeNewswire

Earnings Scheduled For February 23, 2023 ↗

February 23, 2023

Companies Reporting Before The Bell • ChipMOS TECHNOLOGIES (NASDAQ:IMOS) is likely to report earnings for its fourth quarter.

Via Benzinga

Nautilus Biotechnology Partners with the Translational Genomics Research Institute (TGen) to Investigate Applications of Single-Molecule Proteomic Analysis in Diffuse Intrinsic Pontine Glioma (DIPG)

January 19, 2023

Collaboration enables TGen to gain access to data generated on prototype versions of Nautilus’ next-generation proteome analysis platform to advance the study of a rare childhood cancer

From Nautilus Biotechnology Inc.

Via GlobeNewswire

Stocks That Hit 52-Week Lows On Tuesday ↗

December 13, 2022

On Tuesday, 49 companies hit new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

December 08, 2022

During Thursday's trading, 138 companies set new 52-week lows.

Via Benzinga

Nautilus Biotechnology Launches “First Access Challenge”

November 16, 2022

Open competition allows researchers to be among the first to access potentially groundbreaking proteomic data through the testing of twelve samples on Nautilus’ single-molecule protein analysis...

From Nautilus Biotechnology Inc.

Via GlobeNewswire

Nautilus Biotechnology Reports Third Quarter 2022 Financial Results

November 01, 2022

From Nautilus Biotechnology Inc.

Via GlobeNewswire

Nautilus Biotechnology to Announce Third Quarter 2022 Financial Results on November 1, 2022

October 05, 2022

From Nautilus Biotechnology Inc.

Via GlobeNewswire

$7.3 Million Bet On This Penny Stock? Check Out These 4 Penny Stocks Insiders Are Buying ↗

August 23, 2022

The Dow Jones dropped more than 600 points on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern...

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

August 19, 2022

Via Benzinga

Earnings Scheduled For November 1, 2022 ↗

November 01, 2022

Companies Reporting Before The Bell • BP (NYSE:BP) is estimated to report quarterly earnings at $2.07 per share on revenue of $64.76 billion.

Via Benzinga

Why GigaCloud Technology Jumped 206%; Here Are 79 Biggest Movers From Yesterday ↗

August 22, 2022

Gainers GigaCloud Technology Inc (NASDAQ: GCT) shares jumped 206% to close at $48.01 on Friday on continued volatility following the company's IPO on Thursday.

Via Benzinga

$1.2 Million Bet On Gannett? Check Out These 3 Penny Stocks Insiders Are Buying ↗

August 09, 2022

U.S. stock futures traded slightly higher this morning on Tuesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or...

Via Benzinga

Biotech Daily: Trial Setback For Eliem Therapeutics, Allarity Drops Work On Cancer Monotherapies, Axcella Aces Long COVID Study ↗

August 02, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.